EMR
August 7, 2024 - AI Summary
Overvalued by 66.2% based on the discounted cash flow analysis.
Market cap | $62.12 Billion |
---|---|
Enterprise Value | $71.16 Billion |
Dividend Yield | $2.1 (1.93619767656279%) |
Earnings per Share | $23 |
Beta | 1.29 |
Outstanding Shares | 571,900,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 36.15 |
---|---|
PEG | -37.47 |
Price to Sales | 3.74 |
Price to Book Ratio | 2.36 |
Enterprise Value to Revenue | 4.2 |
Enterprise Value to EBIT | -189.76 |
Enterprise Value to Net Income | 41 |
Total Debt to Enterprise | 0.16 |
Debt to Equity | 0.55 |
No data
No data